|
PPP2R5C expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.90889999549671E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.007500E-04 |
| Normal-vs-Stage2 |
4.997300E-03 |
| Normal-vs-Stage3 |
1.77540000034782E-07 |
| Normal-vs-Stage4 |
1.8533999999959E-05 |
| Stage1-vs-Stage2 |
4.451800E-01 |
| Stage1-vs-Stage3 |
7.204800E-03 |
| Stage1-vs-Stage4 |
3.822200E-02 |
| Stage2-vs-Stage3 |
3.462000E-01 |
| Stage2-vs-Stage4 |
4.057000E-01 |
| Stage3-vs-Stage4 |
9.811400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.73040000053903E-07 |
| Normal-vs-AfricanAmerican |
8.32120000000547E-05 |
| Normal-vs-Asian |
1.718020E-01 |
| Caucasian-vs-AfricanAmerican |
4.626000E-01 |
| Caucasian-vs-Asian |
6.875200E-01 |
| AfricanAmerican-vs-Asian |
4.333800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.54189999990173E-07 |
| Normal-vs-Female |
2.24819999999903E-05 |
| Male-vs-Female |
5.657000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.162290E-03 |
| Normal-vs-Age(41-60Yrs) |
9.043300E-04 |
| Normal-vs-Age(61-80Yrs) |
3.42380002127385E-09 |
| Normal-vs-Age(81-100Yrs) |
3.70600000000332E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.526600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.782200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.029000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.278200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.466400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.341400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.456200E-01 |
| Normal-vs-Grade 2 |
1.676550E-03 |
| Normal-vs-Grade 3 |
9.7200003601472E-10 |
| Normal-vs-Grade 4 |
3.59600000000571E-05 |
| Grade 1-vs-Grade 2 |
1.407440E-01 |
| Grade 1-vs-Grade 3 |
5.162000E-03 |
| Grade 1-vs-Grade 4 |
2.017500E-03 |
| Grade 2-vs-Grade 3 |
1.199700E-03 |
| Grade 2-vs-Grade 4 |
1.210010E-02 |
| Grade 3-vs-Grade 4 |
7.414200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.539600E-03 |
| Normal-vs-ccB subtype |
4.334100000003E-06 |
| ccA subtype-vs-ccB subtype |
5.546200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.64661999999538E-05 |
| Normal-vs-N1 |
2.322100E-03 |
| N0-vs-N1 |
1.475580E-01 |
|
|
